IMIC(SZ:000516) Sou Hu Cai Jing·2026-01-19 01:13Core Viewpoint - International Medical (000516) experienced a significant decline in stock price, closing at 5.19 yuan on January 16, 2026, down 6.82% with a trading volume of 1.966 million hands and a turnover of 1.033 billion yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, International Medical reported a main revenue of 2.995 billion yuan, a year-on-year decrease of 16.94% [3] - The net profit attributable to shareholders was -294 million yuan, down 38.45% year-on-year, while the net profit excluding non-recurring items was -312 million yuan, a decline of 41.94% [3] - In Q3 2025, the company recorded a single-quarter main revenue of 961 million yuan, a year-on-year decrease of 18.95%, and a net profit attributable to shareholders of -129 million yuan, down 234.24% year-on-year [3] - The company's debt ratio stands at 68.8%, with investment income of 20.7586 million yuan and financial expenses of 111 million yuan, resulting in a gross margin of 6.59% [3] Group 2: Market Activity - On January 16, 2026, the net outflow of main funds was 27.5033 million yuan, accounting for 2.66% of the total turnover, while retail investors saw a net inflow of 52.6397 million yuan, representing 5.1% of the total turnover [1] - In the financing aspect, the company had a financing buy of 96.5524 million yuan and a financing repayment of 82.2475 million yuan, resulting in a net financing increase of 14.3049 million yuan [2] - The total financing and securities balance is reported at 394 million yuan [2] Group 3: Analyst Ratings - Over the past 90 days, two institutions have given a rating of "buy" for International Medical, with an average target price of 5.5 yuan [4]